Why they are useful. Monoclonal antibodies are identical and all have the same antigen-binding site, so they bind only one specific antigen. Because they are made by cloned hybridoma cells, large quantities of identical antibody can be produced.
Diagnosis. A label (a fluorescent dye, a radioactive substance or a coloured particle) can be attached to the antibody. The antibody binds wherever its antigen is present, so the label shows whether the antigen is present and where it is. For example, pregnancy test strips detect the hormone hCG in urine, and labelled antibodies injected into the body can locate cancer cells or blood clots in a scan. Tests are fast and can detect very small quantities of antigen.
Treatment. An antibody specific to an antigen found only on target cells (e.g. a protein on cancer cells) binds only to those cells. A drug, toxin or radioactive substance attached to it is therefore carried directly to the target cells, so fewer healthy cells are harmed and a smaller dose is needed. Unlabelled antibodies can also block receptors or signalling molecules, or mark target cells for destruction by phagocytes.
Limitations. Antibodies made in mice are non-self proteins, so the patient's immune system may respond to them; repeated doses become less effective and can cause reactions (humanised antibodies reduce this). The target antigen may also be present on some healthy cells, causing side effects. Antibodies are broken down in the body, so treatment is passive and must be repeated, and development is slow and expensive.